Intravenous Infusions plc Reports Unaudited Earnings Results for the Six Months Ended June 30, 2018
Intravenous Infusions Plc reported unaudited earnings results for the six months ended June 30, 2018. For the period, the company reported revenue of GHS 10,051,384 against GHS 6,316,853 a year ago. Operating profit was GHS 2,517,221 against GHS 1,522,056 a year ago. Profit before finance cost and tax was GHS 2,517,221 against GHS 1,522,056 a year ago. Profit before tax was GHS 2,251,330 against GHS 1,110,934 a year ago. Profit for the period was GHS 1,829,206 or GHS 0.00807 per share against GHS 902,634 or GHS 0.00398 per share a year ago. Net cash from operating activities was GHS 323,599 against GHS 546,186 a year ago. Purchases of equipment was GHS 290,291 against GHS 253,858 a year ago.